No preventive or therapeutic efficacy of infliximab against macrophage activation syndrome due to systemic juvenile idiopathic arthritis

Macrophage activation syndrome (MAS) is a secondary haemophagocytic lymphohistiocytosis that is a life-threatening complication of rheumatic diseases. Marked elevation of multiple proinflammatory c...